The GINA guidelines were updated in 2021, yet providers may not have rolled out the recent changes in practice. JAMA Clinical Guidelines Synopsis highlighted the major recommendations, including SMART therapy (single maintenance and reliever therapy) with an “A” recommendation. Join host Geoff Wall as he talks about implementing new recommendations into practice with community pharmacist and patient, Jake Galdo.

The GameChanger

Single Maintenance and Reliever Therapy (SMART) is the new standard in asthma management. Inhaled Corticosteroid (ICS) plus formoterol is the medication of choice for maintenance and reliever care in asthma.

Show Segments
00:00 – Introductions
3:30 – Background on Asthma
05:06 – GINA Guidelines on Asthma
12:40 – Gamechanger: SMART Therapy
17:08 - Connecting to Practice
29:20 – Closing Remarks


Host
Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Guest
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc

References and resources:

• Therapy for Mild to Moderate Asthma. JAMA. 
• Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes

Redeem your CPE or CME credit

• CPE (Pharmacist)
• CME (Physician) 

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) 

• Pharmacists: Get a Membership 
• Prescribers: Get a Membership  

Continuing Education Information:
Learning Objectives:
1. Discuss the primary and secondary track of asthma treatment according to the GINA guidelines
2. Discuss with patients why the SMART approach to using inhalers to relieve immediate symptoms is preferred.

All relevant financial relationships have been mitigated. 

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-350-H01-P
Initial release date: 09/12/22
Expiration date: 09/12/2023
Additional CPE & CME details can be found here 

Follow CEimpact on Social Media:
LinkedIn
Instagram